Ignite Creation Date:
2025-12-24 @ 2:42 PM
Ignite Modification Date:
2025-12-29 @ 5:39 PM
Study NCT ID:
NCT04677959
Status:
COMPLETED
Last Update Posted:
2023-03-14
First Post:
2020-12-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FSS-AS-40139
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None